Stanford’s Innovative Blood Test Offers New Hope for Hodgkin Lymphoma Patients
Stanford Medicine’s research on Hodgkin lymphoma utilizes circulating tumor DNA to forecast treatment outcomes and identifies two genetic cancer groups, promising personalized therapy. Circulating tumor DNA predicts recurrence and splits disease into two …